期刊
JOURNAL OF CONTROLLED RELEASE
卷 162, 期 1, 页码 45-55出版社
ELSEVIER
DOI: 10.1016/j.jconrel.2012.05.051
关键词
Emerging multidrug resistance; Nanotechnology; Drug delivery system; Chemotherapy; Tumor
资金
- Natural Science Foundation of China (NSFC) [30801444]
- Natural Science Foundation of Hebei Province [C2009000693, H2012208020]
- Hebei University of Science and Technology Discipline Construction Office
- State Key Laboratory Breeding Base-Hebei Key Laboratory of Molecular Chemistry For Drug
Emerging multidrug resistance (MDR) to chemotherapy is amajor obstacle in successfully treatingmalignant diseases. Nanotechnology provides an innovative and promising alternative strategy compared to conventional small molecule chemotherapeutics to circumvent MDR. This review focuses on recent literature examples of nanotechnology applications to overcome MDR. The advantages and limitations of various nanotechnologies are discussed as well as possible approaches to overcome the limitations. Developing a practical nanotechnology-based drug delivery system requires further studies of the tumor microenvironment, the mechanisms of MDR to chemotherapy, the optimal dosage regimen of anticancer drugs and/or siRNA, the transport kinetics of nanocarriers in tumor stroma and the pharmacokinetics of drug-loaded nanocarriers within MDR tumor cells. (C) 2012 Elsevier B. V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据